跳至主要内容
临床试验/IRCT20120718010333N5
IRCT20120718010333N5已完成3 期

Comparison of the effect of vitamin B12 supplement with placebo on grade of liver steatosis and fibrosis based on the results of elastography in patients with Non-Alcoholic Fatty Liver Disease

Kashan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Patients who are diagnosed to have non alcoholic fatty liver disease confirmed with ultrasonography result
  • Ages between 18-80 years
  • Serum alanine transaminase enzyme level higher than 30 U/L in men
  • Serum alanine transaminase enzyme level higher than 19 U/L in women

排除标准

  • Alcohol consumption greater than 20 g per day
  • Having diseases such as hereditary hemochromatosis, Wilson's disease and a1 antitripsin enzyme deficiency
  • History of jejunoileal bypass surgery or gastroplasty
  • History of receiving total parenteral nutrition during last 6 months
  • Consumption of statins and hepatotoxic drugs such as calcium channel blocker, methotrexate, amiodarone, chloroquine
  • History of hypothyroidism and Cushing's syndrome
  • Intake of folate, B12, vitamin E and omega-3 supplements during the last 3 months

研究者

相似试验